Professor Allan Young talks us through the improvements in diagnosis of bipolar I disorder that he feels the new DSM-5 will bring and the long-term changes in drug research and disease classification that he expects the new criteria to spark
Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.
390
